newsfilter
← Latest News
GlobeNewswire·

Agios' PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA's Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and